Goetsch, Liliane <br/><br/>
A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts.  [electronic resource] 

 -  International journal of cancer  Jan 2005 
 - 316-28 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/ijc.20543  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Breast Neoplasms--pathology<br/>Carcinoma, Hepatocellular--pathology<br/>Carcinoma, Non-Small-Cell Lung--pathology<br/>Cell Cycle--drug effects<br/>Drug Interactions<br/>ErbB Receptors--physiology<br/>Female<br/>Humans<br/>Liver Neoplasms--pathology<br/>Lung Neoplasms--pathology<br/>Mice<br/>Mice, Nude<br/>Receptor, IGF Type 1--immunology<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured<br/>Vinblastine--analogs & derivatives<br/>Vinorelbine